The Intramedullary Nail Market is estimated to be valued at US$ 1.95 billion in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
The Intramedullary Nail Market refers to the market for orthopedic implants used in the treatment of various fractures. Intramedullary nails are commonly used in orthopedic surgeries to stabilize and repair long bone fractures. These nails are inserted into the medullary cavity of the bone, providing internal support and facilitating bone healing. They are widely used in the treatment of fractures in the femur, tibia, and humerus, among others. The market offers a wide range of intramedullary nail products, including different sizes, shapes, and materials to suit individual patient requirements.
The growth of the Intramedullary Nail Market is primarily driven by the increasing incidences of fractures, especially among the geriatric population. With the aging population, the risk of fractures increases, thereby driving the demand for orthopedic implants such as intramedullary nails. Additionally, advancements in orthopedic surgeries and techniques, such as minimally invasive procedures, have further boosted market growth. Minimally invasive surgeries offer benefits such as reduced post-operative pain, faster recovery, and smaller incisions. These factors contribute to the market’s growth potential. Furthermore, technological advancements in intramedullary nail designs, such as locking mechanisms and improved biocompatible materials, are expected to drive market expansion in the coming years. Overall, the Intramedullary Nail Market is poised for significant growth, driven by the rising demand for orthopedic implants and advancements in surgical techniques.
The intramedullary nail market can be segmented based on type, material, end-user, and region. By type, the dominating segment is the femoral nails segment. This dominance is attributed to the increasing number of femoral fractures and the growing preference for intramedullary nail fixation for femoral fractures. Femoral nails provide better stability and support for fractured femurs, leading to faster healing and improved patient outcomes.
Political: The government regulations regarding medical device approvals and reimbursement policies play a significant role in shaping the intramedullary nail market.
Economic: The economic factors such as healthcare expenditure, GDP growth rate, and disposable income influence the adoption of intramedullary nails, as they require significant investment.
Social: The increasing geriatric population and a rise in sports-related injuries contribute to the market growth of intramedullary nails.
Technological: Advancements in technology, such as the introduction of biodegradable intramedullary nails and computer-assisted surgical techniques, are driving the market growth of intramedullary nails.
The Global Intramedullary Nail Market Size is expected to witness high growth, exhibiting a CAGR of 8.5% over the forecast period, due to increasing femoral fractures resulting from factors like accidents, sports injuries, and osteoporosis. The femoral nails segment dominates the market, as they provide better stability and support during the healing process.
Regionally, North America is the fastest-growing and dominating region in the intramedullary nail market. This can be attributed to the well-established healthcare infrastructure, increasing healthcare expenditure, and a high prevalence of femoral fractures in the region.
Key players operating in the intramedullary nail market include Zimmer Biomet, Smith & Nephew, Stryker, DePuy Synthes, Orthofix, Bioventus LLC, DJO Global, Braun, Medtronic, and Globus Medical. These key players are focused on product development, strategic collaborations, and mergers and acquisitions to strengthen their market presence and gain a competitive edge.